Order Article Reprints

Ávalos I, Lao T, Rodríguez EM, Zamora Y, Rodríguez A, Ramón A, Lemos G, Cabrales A, Bequet-Romero M, Casillas D, et al. Chimeric Antigen by the Fusion of SARS-CoV-2 Receptor Binding Domain with the Extracellular Domain of Human CD154: A Promising Improved Vaccine Candidate. Vaccines. 2022; 10(6):897. https://doi.org/10.3390/vaccines10060897

Ávalos, Ileanet, Thailin Lao, Elsa María Rodríguez, Yasser Zamora, Alianet Rodríguez, Ailyn Ramón, Gilda Lemos, Ania Cabrales, Monica Bequet-Romero, Dionne Casillas, and et al. 2022. "Chimeric Antigen by the Fusion of SARS-CoV-2 Receptor Binding Domain with the Extracellular Domain of Human CD154: A Promising Improved Vaccine Candidate" Vaccines 10, no. 6: 897. https://doi.org/10.3390/vaccines10060897

Ávalos, I., Lao, T., Rodríguez, E. M., Zamora, Y., Rodríguez, A., Ramón, A., Lemos, G., Cabrales, A., Bequet-Romero, M., Casillas, D., Andújar, I., Espinosa, L. A., González, L. J., Alvarez, Y., Carpio, Y., & Estrada, M. P. (2022). Chimeric Antigen by the Fusion of SARS-CoV-2 Receptor Binding Domain with the Extracellular Domain of Human CD154: A Promising Improved Vaccine Candidate. Vaccines, 10(6), 897. https://doi.org/10.3390/vaccines10060897